Chondroitin sulphate is better for knee joint health than Celebr.

According to a study conducted under the direction of Jean-Pierre Pelletier of the Rheumatology Research Institute in Montreal, Canada, chondroitin sulfate was superior to the anti-inflammatory drug Celebrex in reducing pain in the knee joint and preventing wear and tear of the joints associated with osteoarthritis.

Chondroitin effectively delayed the progression of the disease while improving functional capacity and relieving pain. Patients participating in the study took either 1,200 milograms of chondroitin sulfate or 200 mg of the drug Celebrex per day over a two-year period. Chondroitin had the best long-term effect on the progression of arthritis, with both treatments effectively reducing symptoms.

(A paper presented at the annual meeting of the American Academy of Rheumatology in 2015)